To to many to count ........................
darknutbag, daffyduckoutonight .....................ect
Oh you mean his 20 or 30 posting Id's My Bad
The #2 nutbag is alive and posting .... what relevance only daffy duckoutonight the #1 nutbag can truely make antisense of. Do u clowns ever get tired of talking out your (_O_)'s. I quess not with all the crappyolla that u spew.
crappyolla all over the place but please don't wash with it you smell bad as it is.
Hey fnuts I realize your try'n your hardest to take over the #2 spot from macronut but your posts just don't cut it.
please try just a little bit more nutty and I may reward you with a big bag of #2
He's try'n like the blowHard he is to replace sourdodo as the #2 board nut bag
Since sour has retired I can give kelly the "dodo" ........... He posts like a sh*tforbrains.
Who let Macronut out to play? daffy duck he will never be, always #3 on the nutbag list
The pipeline besides TED is years away from the market. and sales of TED could be as low as $400M or as High as $1B. So why take on all the expense and complexity of becoming a Sales and Marketing Biotech. To detail a single drug is an expensive proposition.
Sad very sad .... thats all you got
another intellectual moronic fool you sits down to take a peeeeepeeee
Only a reasonable percentage of ones portfolio should be made up of speculative type stocks. i also own NBIX and ISIS. risk/money management principle #1.
We know nothing untill we know P3 results.
WOW your post is almost as intellectual as post 's from daffy duckoutonoght.
very impressive for talking out the wrong end of the horse
Has it been 16 years since daffy duckoutonight got fired from ISIS
daffy where is your secret decoder ring that tells the future of ISIS
did Zack the dog eat it??? or are you sitting on it ...... zippo!!!!!!!!
sourdodo the #2 blowhard on this board second only to daffy duckoutonight.
I just need to know are you a real true SKIRTBOY? LMFAOAU
We will get a much better understanding of Synergy trial results in early Q1/14 as there are multiple biotech conferences. Most likely we will be buying May/June 2014 puts for insurance.
The stock will rise in price as we get closer to 2014 news flow that impacts the investment timing of put options more than the actual event.
IMO, the later the better on survival benefit results.